# FDA Inspection 1221101 - Grifols Therapeutics LLC - September 01, 2023

Source: https://www.keypedia.com/records/fda_inspections/grifols-therapeutics-llc/8955f0eb-74f7-40f8-be3a-2ebaa64a50c8
Source feed: FDA_Inspections

> FDA Inspection 1221101 for Grifols Therapeutics LLC on September 01, 2023. Classification: N/A.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1221101
- Company Name: Grifols Therapeutics LLC
- Inspection Date: 2023-09-01
- Office Name: Atlanta District Office

## Related Documents

- [FDA Inspection 1302186 - 2026-02-05](https://www.keypedia.com/records/fda_inspections/grifols-therapeutics-llc/34708a56-41e8-4e87-bab0-c702d71a2713)
- [FDA Inspection 1176467 - 2022-05-06](https://www.keypedia.com/records/fda_inspections/grifols-therapeutics-llc/22e93194-bc84-49e1-8de7-445532cdee68)
- [FDA Inspection 1176467 - 2022-05-06](https://www.keypedia.com/records/fda_inspections/grifols-therapeutics-llc/9cf52920-d34b-4f87-840d-e52213631e5a)
- [FDA Inspection 1079999 - 2018-12-13](https://www.keypedia.com/records/fda_inspections/grifols-therapeutics-llc/a8c4df93-a1d3-415f-a6ee-5067a6f6675c)
- [FDA Inspection 994781 - 2016-10-21](https://www.keypedia.com/records/fda_inspections/grifols-therapeutics-llc/9a41f385-bd40-454e-bfcf-1cf95a896584)

Company: https://www.keypedia.com/companies/grifols-therapeutics-llc/2e4dd489-4e70-4ef7-a1f8-f0267f91fab5

Office: https://www.keypedia.com/offices/atlanta-district-office/7586d99a-288e-49d1-8c3d-d88b7354b7a7